Ignite Creation Date:
2024-05-06 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03524118
Status:
COMPLETED
Last Update Posted:
2023-11-29
First Post:
2018-05-11
Brief Title:
Safety Tolerability and Pharmacokinetics of Clesrovimab MK-1654 in Infants MK-1654-002
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-20
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-14
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-11
First Submit QC Date:
May 11 2018
Study First Post Date:
2018-05-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-11-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-10
Last Update Post Date:
2023-11-29
Last Update Post Date Type:
ACTUAL